Daré Bioscience, Inc.

US$0.64As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DAREHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR (36.12%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.15
PE TTM —
TSR TTM (67.40%)
Mkt cap US$12.57M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.785
22.82%
(43.21%)
Buy 10|4|12|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
11.85%
8.73%
2.77%
(6.45%)
Revenue$M
0.620
0.626
0.636
0.626
6.58%
5.38%
1.13%
(1.07%)
Peers (US$12.57M)
Cap (US$)
PE
12.58M
—
Capital
TTM
5Y
10Y
Leveragex
0.250
0.075
0.074
EBIT/Intx
1.271
0.514
0.505
Own earn%
10.43
(126.49)
(114.26)
Sh yield%
47.55
35.00
34.65
Owners
Insiders/Inst%
9.69
88.90
Short interest%
0.80
SBC / revenue%
3.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
28–33
$1 testx
—
Incr. ROIC%
0